Taken together these data point to an important role for GSK3β and β-catenin in cadherin-11 mRNA and protein homeostasis and may lead to the development of therapeutics for diseases such as, metastatic prostate and breast cancer and rheumatoid arthritis, that are characterized by elevated cadherin-11. The gene discussed is GSK3B; the disease is breast cancer.